Case-control study

Drug and Alcohol Rehabilitation: Multiscale Simulation as a Framework for the Enhanced Design of Nanodiamond-Polyethylenimine-Based Gene Delivery.

Published January 11, 2013

Multiscale Simulation as a Framework for the Enhanced Design of Nanodiamond-Polyethylenimine-based Gene Delivery.

Filed under: Drug and Alcohol Rehabilitation

J Phys Chem Lett. 2012 Dec 4; 3(24): 3791-3797
Kim H, Man HB, Saha B, Kopacz AM, Lee OS, Schatz… Continue reading →

Addiction Rehab: Low Incidence of HCV Amongst Prisoners in Scotland.

Published January 11, 2013

Low incidence of HCV amongst prisoners in Scotland.

Filed under: Addiction Rehab

Addiction. 2013 Jan 8;
Taylor A, Munro A, Allen E, Dunleavy K, Cameron S, Miller L, Hickman M

AIMS: To estimate HCV incidence and HCV risk among… Continue reading →

Eating Disorders: Screening for Impulse Control Symptoms in Patients With De Novo Parkinson Disease: A Case-Control Study.

Published January 10, 2013

Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study.

Filed under: Eating Disorders

Neurology. 2013 Jan 8; 80(2): 176-180
Weintraub D, Papay K, Siderowf A,

OBJECTIVE: To determine the frequency and correlates of… Continue reading →

Addiction Rehab: Lack of Association of a Functional Catechol-O-Methyltransferase Gene Polymorphism With Risk of Tobacco Smoking: Results From a Multicenter Case-Control Study.

Published January 5, 2013

Lack of Association of a Functional Catechol-O-Methyltransferase Gene Polymorphism With Risk of Tobacco Smoking: Results From a Multicenter Case-Control Study.

Filed under: Addiction Rehab

Nicotine Tob Res. 2013 Jan 3;
Mutschler J, Abbruzzese E, von der Goltz C, Dinter… Continue reading →

Depression Treatment: Association Between Reported Venlafaxine Use in Early Pregnancy and Birth Defects, National Birth Defects Prevention Study, 1997-2007.

Published January 4, 2013

Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.

Filed under: Depression Treatment

Birth Defects Res A Clin Mol Teratol. 2012 Dec 26;
Polen KN, Rasmussen SA, Riehle-Colarusso T, Reefhuis J,… Continue reading →

Addiction Rehab: Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients.

Published January 2, 2013

Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients.

Filed under: Addiction Rehab

J Clin Psychopharmacol. 2012 Dec 28;
Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA,… Continue reading →

Depression Treatment: Escitalopram for the Management of Major Depressive Disorder: A Review of Its Efficacy, Safety, and Patient Acceptability.

Published December 29, 2012

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.

Filed under: Depression Treatment

Patient Prefer Adherence. 2012; 6: 853-61
Kirino E

Escitalopram (escitalopram oxalate; Cipralex(®), Lexapro(®)) is a selective serotonin reuptake… Continue reading →

Depression Treatment: Effect of Comorbidity on Treatment of Anxious Children and Adolescents: Results From a Large, Combined Sample.

Published December 27, 2012

Effect of comorbidity on treatment of anxious children and adolescents: results from a large, combined sample.

Filed under: Depression Treatment

J Am Acad Child Adolesc Psychiatry. 2013 Jan; 52(1): 47-56
Rapee RM, Lyneham HJ, Hudson JL, Kangas M, Wuthrich… Continue reading →

Drug and Alcohol Rehabilitation: Benzonatate Toxicity in a Teenager Resulting in Coma, Seizures, and Severe Metabolic Acidosis.

Published December 22, 2012

Benzonatate toxicity in a teenager resulting in coma, seizures, and severe metabolic acidosis.

Filed under: Drug and Alcohol Rehabilitation

J Pediatr Pharmacol Ther. 2012 Jul; 17(3): 270-3
Thimann DA, Huang CJ, Goto CS, Feng SY

We report a benzonatate… Continue reading →

Could Hypomanic Traits Explain Selective Migration? Verifying the Hypothesis by the Surveys on Sardinian Migrants.

Published December 19, 2012

Could hypomanic traits explain selective migration? Verifying the hypothesis by the surveys on sardinian migrants.

Filed under: Depression Treatment

Clin Pract Epidemiol Ment Health. 2012; 8: 175-9
Giovanni CM, Francesca MM, Viviane K, Brasesco MV, Bhat KM, Matthias AC,… Continue reading →

Drug and Alcohol Rehabilitation: Multiscale Simulation as a Framework for the Enhanced Design of Nanodiamond-Polyethylenimine-Based Gene Delivery.

Addiction Rehab: Low Incidence of HCV Amongst Prisoners in Scotland.

Eating Disorders: Screening for Impulse Control Symptoms in Patients With De Novo Parkinson Disease: A Case-Control Study.

Addiction Rehab: Lack of Association of a Functional Catechol-O-Methyltransferase Gene Polymorphism With Risk of Tobacco Smoking: Results From a Multicenter Case-Control Study.

Depression Treatment: Association Between Reported Venlafaxine Use in Early Pregnancy and Birth Defects, National Birth Defects Prevention Study, 1997-2007.

Addiction Rehab: Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients.

Depression Treatment: Escitalopram for the Management of Major Depressive Disorder: A Review of Its Efficacy, Safety, and Patient Acceptability.

Depression Treatment: Effect of Comorbidity on Treatment of Anxious Children and Adolescents: Results From a Large, Combined Sample.

Drug and Alcohol Rehabilitation: Benzonatate Toxicity in a Teenager Resulting in Coma, Seizures, and Severe Metabolic Acidosis.

Could Hypomanic Traits Explain Selective Migration? Verifying the Hypothesis by the Surveys on Sardinian Migrants.

Recent Posts

Search this Site